Portman Square Capital »

Bridgebio Pharma shares owned by Portman Square Capital

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Portman Square Capital from 13F filings

Historical chart of Portman Square Capital investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Portman Square Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Portman Square Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $24M 774k 30.92
2023-12-31 $34M 832k 40.37
2023-09-30 $29M 1.1M 26.37

More positions owned by Portman Square Capital

Shift4 Pmts Cl A Put Option (FOUR)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Live Nation Entertainment (LYV)
Akamai Technologies Put Option (AKAM)
Middleby Corporation Put Option (MIDD)
Peabody Energy Put Option (BTU)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
American Airls Put Option (AAL)
Seagate Technology Hldngs Pl Ord Shs Put Option (STX)
Western Digital (WDC)
Metropcs Communications Put Option (TMUS)
Meta Platforms Cl A Call Option (META)
Cleveland-cliffs Call Option (CLF)
Micron Technology Put Option (MU)
Advanced Micro Devices Call Option (AMD)

View all positions for Portman Square Capital

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
Aisling Capital Management
Laurion Capital Management
Cormorant Asset Management
Goldman Sachs Group
Lord, Abbett & Co
Frazier Life Sciences Management
Alliancebernstein
Perceptive Advisors
Citigroup
Wellington Management Company
Hillhouse Capital Advisors
Norges Bank Investment Management

View all funds holding Bridgebio Pharma